Tuesday, November 17, 2026 Vol. I · No. 5
Health · Via STAT

STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more

Image: STAT

The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk